title: The development and application of the two real-time RT-PCR assays to detect the pathogen of HFMD.
abstract: Large-scale Hand, Foot, and Mouth Disease (HFMD) outbreaks have frequently occurred in China since 2008, affecting more than one million children and causing several hundred children deaths every year. The pathogens of HFMD are mainly human enteroviruses (HEVs). Among them, human enterovirus 71 (HEV71) and coxsackievirus A16 (CVA16) are the most common pathogens of HFMD. However, other HEVs could also cause HFMD. To rapidly detect HEV71 and CVA16, and ensure detection of all HEVs causing HFMD, two real-time hybridization probe-based RT-PCR assays were developed in this study. One is a multiplex real-time RT-PCR assay, which was developed to detect and differentiate HEV71 specifically from CVA16 directly from clinical specimens within 1-2 h, and the other is a broad-spectrum real-time RT-PCR assay, which targeted almost all HEVs. The experiments confirmed that the two assays have high sensitivity and specificity, and the sensitivity was up to 0.1 TCID50/ml for detection of HEVs, HEV71, and CVA16, respectively. A total of 213 clinical specimens were simultaneously detected by three kinds of assays, including the two real-time RT-PCR assays, direct conventional RT-PCR assay, and virus isolation assay on human rhabdomyosarcoma cells (RD cells). The total positive rate of both HEV71 and CVA16 was 69.48% with real-time RT-PCR assay, 47.42% with RT-PCR assay, and 34.58% with virus isolation assay. One HFMD clinical specimen was positive for HEV, but negative for HEV71 or CVA16, which was identified as Echovirus 11 (Echo11) by virus isolation, RT-PCR, and sequencing for the VP1 gene. The two real-time RT-PCR assays had been applied in 31 provincial HFMD labs to detect the pathogens of HFMD, which has contributed to the rapid identification of the pathogens in the early stages of HFMD outbreaks, and helped to clarify the etiologic agents of HFMD in China.
authors: National Institute for Viral Disease Control and Prevention, China CDC, Beijing, PR China.
authors: Aili
authors: A
authors: Cui
authors: Changping
authors: C
authors: Xu
authors: Xiaojuan
authors: X
authors: Tan
authors: Yan
authors: Y
authors: Zhang
authors: Zhen
authors: Z
authors: Zhu
authors: Naiying
authors: N
authors: Mao
authors: Yiyu
authors: Y
authors: Lu
authors: Wenbo
authors: W
authors: Xu
mesh_terms: D002648:Child; D002681:China / Q000453:epidemiology; D004196:Disease Outbreaks; D004770:Enterovirus / Q000302:isolation & purification; D029821:Enterovirus A, Human / Q000302:isolation & purification; D006232:Hand, Foot and Mouth Disease / Q000453:epidemiology / Q000401:mortality / Q000821:virology*; D006801:Humans; D012367:RNA, Viral / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity
chemical_list: D012367:RNA, Viral
references: J Immunol. 1960 Mar;84:309-17
references: 14416964
references: J Virol Methods. 2002 Apr;102(1-2):9-14
references: 11879688
references: Emerg Infect Dis. 2004 Feb;10(2):311-6
references: 15030703
references: N Engl J Med. 1999 Sep 23;341(13):929-35
references: 10498487
references: J Clin Virol. 2009 Apr;44(4):262-7
references: 19269888
references: Emerg Infect Dis. 2003 Apr;9(4):461-8
references: 12702227
references: J Clin Microbiol. 2001 Jan;39(1):196-200
references: 11136770
references: J Clin Microbiol. 2006 Aug;44(8):2698-704
references: 16891480
references: Nucleic Acids Res. 2002 Mar 15;30(6):1292-305
references: 11884626
references: J Clin Microbiol. 2002 Aug;40(8):2823-7
references: 12149336
references: Clin Infect Dis. 2002 May 1;34 Suppl 2:S52-7
references: 11938497
references: J Clin Microbiol. 2001 Oct;39(10):3690-2
references: 11574592
references: J Virol. 1999 Mar;73(3):1941-8
references: 9971773
references: J Clin Virol. 2000 Apr;16(2):107-12
references: 10720814